| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Medicus Pharma Ltd. | Director | Stock Option (right to buy) | 25K | $138K | $5.50 | Jul 22, 2025 | Direct |
| Baudax Bio, Inc. | Director | Common Stock | 42.5K | $13.2K | $0.31 | Jun 15, 2022 | Direct |
| Societal CDMO, Inc. | Director | Common Stock | 0 | $0 | $1.10 | Apr 8, 2024 | Direct |
| Medicus Pharma Ltd. | Director | Common Shares, no par value ("Common Shares") | 1.25K | Dec 31, 2024 | Direct | ||
| Societal CDMO, Inc. | Director | Stock Option (Right to Buy) | 0 | Apr 8, 2024 | Direct | ||
| SPECTRUM PHARMACEUTICALS INC | Director | Common Stock, $0.001 par value | 0 | $1.10 | Jul 31, 2023 | Direct | |
| SPECTRUM PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | Jul 31, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MDCX | Medicus Pharma Ltd. | Jul 22, 2025 | 1 | $0 | 4 | Jul 24, 2025 | Director |
| MDCX | Medicus Pharma Ltd. | Dec 31, 2024 | 0 | $0 | 3/A | Jan 23, 2025 | Director |
| SCTL | Societal CDMO, Inc. | Apr 8, 2024 | 4 | -$290K | 4 | Apr 8, 2024 | Director |
| SCTL | Societal CDMO, Inc. | Aug 28, 2023 | 1 | $10.1K | 4 | Aug 28, 2023 | Director |
| SPPI | SPECTRUM PHARMACEUTICALS INC | Jul 31, 2023 | 2 | $0 | 4 | Aug 1, 2023 | Director |
| SCTL | Societal CDMO, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
| SPPI | SPECTRUM PHARMACEUTICALS INC | Aug 31, 2022 | 2 | $0 | 4 | Sep 2, 2022 | Director |
| SPPI | SPECTRUM PHARMACEUTICALS INC | Jun 21, 2022 | 1 | -$3.36K | 4 | Jun 22, 2022 | Director |
| BXRX | Baudax Bio, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| SCTL | Societal CDMO, Inc. | May 18, 2022 | 2 | $0 | 4 | May 20, 2022 | Director |
| SPPI | SPECTRUM PHARMACEUTICALS INC | Jun 17, 2021 | 3 | -$38.2K | 4 | Jun 22, 2021 | Director |
| SCTL | Recro Pharma, Inc. | Apr 20, 2021 | 1 | $0 | 4/A | May 17, 2021 | Director |